Who
Kimberly Gentile
SVP, Clinical Operations
Company insider
Files Form 4 as: SVP, Clinical Operations, Biohaven; SVP, Clinical Operations, Biohaven Pharmaceutical Holding Co.
In numbers
- Trades disclosed
- 148
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $6.1M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 5 Sep 2017
- Last trade
- 15 Sep 2026
- Last filed
- 17 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 17 Sep 2026 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,000 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | BHVN BiohavenBiotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | BHVN BiohavenBiotechnology | SEC FORM 4 Code F | $19K1,956 at $9.93 | filing |
| 5 Jan 2026filed 7 Jan 2026 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | BHVN BiohavenBiotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | BHVN BiohavenBiotechnology | SEC FORM 4 Code F | $19K1,956 at $9.93 | filing |
| 5 Jan 2025filed 7 Jan 2025 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —91,000 at $0.00 | filing |
| 5 Jan 2025filed 7 Jan 2025 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 5 Jan 2025filed 7 Jan 2025 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 5 Jan 2025filed 7 Jan 2025 | BHVN BiohavenBiotechnology | SEC FORM 4 Code M | —3,750 at $0.00 | filing |
| 5 Jan 2025filed 7 Jan 2025 | BHVN BiohavenBiotechnology | SEC FORM 4 Code F | $76K1,956 at $38.64 | filing |
| 2 Jan 2024filed 4 Jan 2024 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —96,250 at $0.00 | filing |
| 2 Nov 2023filed 6 Nov 2023 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code A | —78,750 at $0.00 | filing |
| 3 Oct 2022filed 5 Oct 2022 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code J | —387 | filing |
| 3 Oct 2022filed 5 Oct 2022 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code J | —12,612 | filing |
| 3 Oct 2022filed 5 Oct 2022 | BHVN Biohavenoption or derivative · Biotechnology | SEC FORM 4 Code J | —1,199 | filing |
News
No headline names them, or the companies they trade most, lately.